← golden set
IBM
INTERNATIONAL BUSINESS MACHINES CORPTechnology10-K for period ending 2025-12-31filed 2026-02-24accession 0000051143-26-000010filing on sec.gov ↗exhibit 13 ↗
answer key
| field | SEC value | XBRL concept | printed on |
|---|---|---|---|
| Total revenue | $67.5B | Revenues | Total revenue |
| Operating income | - | not reported | not in this filing's XBRL |
| Net income attributable to the company | $10.6B | NetIncomeLoss | Net income (1) |
| Diluted EPS | $11.17 | EarningsPerShareDiluted | Total |
| Cash and cash equivalents | $13.6B | CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents |
| Total assets | $151.9B | Assets | Total assets · Total liabilities and equity |
| Total liabilities | $119.1B | Liabilities | Total liabilities |
| Total shareholders' equity attributable to the company | $32.6B | StockholdersEquity | Total IBM stockholders' equity |
| Net cash from operating activities | $13.2B | NetCashProvidedByUsedInOperatingActivities | Net cash provided by operating activities |
| Net cash from investing activities | -$10.3B | NetCashProvidedByUsedInInvestingActivities | Net cash provided by/(used in) investing activities |
| Net cash from financing activities | -$3.8B | NetCashProvidedByUsedInFinancingActivities | Net cash provided by/(used in) financing activities |
Income statement
table #93 · score 52.3 vs 34 runner-up · in millions| ( in millions except per share amounts) | ||||
| For the year ended December 31: | Notes | 2025 | 2024 | 2023 |
| Revenue | ||||
| Services | 30,714 | 29,813 | 30,378 | |
| Sales | 36,085 | 32,231 | 30,745 | |
| Financing | 737 | 709 | 737 | |
| Total revenue | C | 67,535 | 62,753 | 61,860 |
| Cost | ||||
| Services | 20,975 | 20,529 | 21,051 | |
| Sales | 6,861 | 6,303 | 6,127 | |
| Financing | 403 | 369 | 382 | |
| Total cost | 28,239 | 27,201 | 27,560 | |
| Gross profit | 39,297 | 35,551 | 34,300 | |
| Expense and other (income) | ||||
| Selling, general and administrative | 20,123 | 19,688 | 19,003 | |
| Research and development | 8,316 | 7,479 | 6,775 | |
| Intellectual property and custom development income | (964) | (996) | (860) | |
| Other (income) and expense (1) | F | (442) | 1,871 | (914) |
| Interest expense | O&S | 1,935 | 1,712 | 1,607 |
| Total expense and other (income) | 28,968 | 29,754 | 25,610 | |
| Income from continuing operations before income taxes | 10,328 | 5,797 | 8,690 | |
| Provision for/(benefit from) income taxes (1) | G | (242) | (218) | 1,176 |
| Income from continuing operations | 10,571 | 6,015 | 7,514 | |
| Income/(loss) from discontinued operations, net of tax | 22 | 8 | (12) | |
| Net income (1) | 10,593 | 6,023 | 7,502 | |
| Earnings/(loss) per share of common stock (1) | ||||
| Assuming dilution | ||||
| Continuing operations | H | 11.14 | 6.42 | 8.15 |
| Discontinued operations | H | 0.02 | 0.01 | (0.01) |
| Total | H | 11.17 | 6.43 | 8.14 |
| Basic | ||||
| Continuing operations | H | 11.34 | 6.53 | 8.25 |
| Discontinued operations | H | 0.02 | 0.01 | (0.01) |
| Total | H | 11.36 | 6.53 | 8.23 |
| Weighted-average number of common shares outstanding | ||||
| Assuming dilution | 948,675,228 | 937,161,224 | 922,073,828 | |
| Basic | 932,293,927 | 921,767,834 | 911,210,319 |
Balance sheet
table #97 · score 55 vs 19.3 runner-up · in millions| ( in millions except per share amounts) | |||
| At December 31: | Notes | 2025 | 2024 |
| Assets | |||
| Current assets | |||
| Cash and cash equivalents | 13,587 | 13,947 | |
| Restricted cash | 54 | 214 | |
| Marketable securities | I | 830 | 644 |
| Notes and accounts receivable-trade (net of allowances of $99 in 2025 and $114 in 2024) | C | 8,112 | 6,804 |
| Short-term financing receivables | K | ||
| Held for investment (net of allowances of $106 in 2025 and $109 in 2024) | 7,344 | 6,259 | |
| Held for sale | 1,131 | 900 | |
| Other accounts receivable (net of allowances of $37 in 2025 and $31 in 2024) | 1,052 | 947 | |
| Inventory | J | 1,220 | 1,289 |
| Deferred costs | C | 1,084 | 959 |
| Prepaid expenses and other current assets | 2,530 | 2,520 | |
| Total current assets | 36,944 | 34,482 | |
| Property, plant and equipment | L | 17,874 | 17,691 |
| Less: Accumulated depreciation | L | 11,975 | 11,959 |
| Property, plant and equipment-net | L | 5,899 | 5,731 |
| Operating right-of-use assets-net | M | 3,129 | 3,197 |
| Long-term financing receivables (net of allowances of $34 in 2025 and $19 in 2024) | K | 7,708 | 5,353 |
| Prepaid pension assets | U | 7,544 | 7,492 |
| Deferred costs | C | 825 | 788 |
| Deferred taxes | G | 8,610 | 6,978 |
| Goodwill | N | 67,717 | 60,706 |
| Intangible assets-net | N | 11,391 | 10,660 |
| Investments and sundry assets | 2,112 | 1,787 | |
| Total assets | 151,880 | 137,175 | |
| Liabilities and equity | |||
| Current liabilities | |||
| Taxes | G | 2,347 | 2,033 |
| Short-term debt | I&O | 6,424 | 5,089 |
| Accounts payable | 4,756 | 4,032 | |
| Compensation and benefits | 4,114 | 3,605 | |
| Deferred income | C | 16,101 | 13,907 |
| Operating lease liabilities | M | 800 | 768 |
| Other accrued expenses and liabilities | 4,116 | 3,709 | |
| Total current liabilities | 38,658 | 33,142 | |
| Long-term debt | I&O | 54,836 | 49,884 |
| Retirement and nonpension postretirement benefit obligations | U | 9,018 | 9,432 |
| Deferred income | C | 4,271 | 3,622 |
| Operating lease liabilities | M | 2,547 | 2,655 |
| Other liabilities | P | 9,810 | 11,048 |
| Total liabilities | 119,139 | 109,783 | |
| Commitments and Contingencies | Q | ||
| Equity | R | ||
| IBM stockholders' equity | |||
| Common stock, par value $.20 per share, and additional paid-in capital | 63,318 | 61,380 | |
| Shares authorized: 4,687,500,000 | |||
| Shares issued (2025-2,290,618,523; 2024-2,279,164,313) | |||
| Retained earnings | 155,648 | 151,163 | |
| Treasury stock, at cost (shares: 2025-1,353,666,394; 2024-1,352,874,243) | (170,605) | (169,968) | |
| Accumulated other comprehensive income/(loss) | (15,713) | (15,269) | |
| Total IBM stockholders' equity | 32,648 | 27,307 | |
| Noncontrolling interests | A | 93 | 86 |
| Total equity | 32,740 | 27,393 | |
| Total liabilities and equity | 151,880 | 137,175 |
Cash flow statement
table #99 · score 54 vs 10 runner-up · in millions| ( in millions) | |||
| For the year ended December 31: | 2025 | 2024 | 2023 |
| Cash flows from operating activities | |||
| Net income | 10,593 | 6,023 | 7,502 |
| Adjustments to reconcile net income to cash provided by operating activities | |||
| Pension settlement charges | - | 3,113 | - |
| Depreciation (1) | 2,284 | 2,168 | 2,109 |
| Amortization of capitalized software and acquired intangible assets | 2,737 | 2,499 | 2,287 |
| Stock-based compensation | 1,715 | 1,311 | 1,133 |
| Deferred taxes (2) | (957) | (2,330) | (1,114) |
| Net (gain)/loss on divestitures, asset sales and other | (39) | (652) | (170) |
| Change in operating assets and liabilities, net of acquisitions/divestitures | |||
| Receivables (including financing receivables) | (4,278) | (374) | 725 |
| Retirement related | (50) | 265 | (462) |
| Inventory | 70 | (166) | 390 |
| Other assets/other liabilities (2) | 495 | 1,601 | 1,466 |
| Accounts payable | 624 | (13) | 65 |
| Net cash provided by operating activities | 13,193 | 13,445 | 13,931 |
| Cash flows from investing activities | |||
| Payments for property, plant and equipment | (1,091) | (1,048) | (1,245) |
| Proceeds from disposition of property, plant and equipment/other | 121 | 557 | 321 |
| Investment in software | (647) | (637) | (565) |
| Purchases of marketable securities and other investments | (10,095) | (7,762) | (11,143) |
| Proceeds from disposition of marketable securities and other investments | 9,704 | 6,544 | 10,647 |
| Acquisition of businesses, net of cash acquired | (8,294) | (3,289) | (5,082) |
| Divestiture of businesses, net of cash transferred | (1) | 698 | (4) |
| Net cash provided by/(used in) investing activities | (10,302) | (4,937) | (7,070) |
| Cash flows from financing activities | |||
| Proceeds from new debt | 8,391 | 5,705 | 9,586 |
| Payments to settle debt | (5,489) | (6,615) | (5,082) |
| Short-term borrowings/(repayments) less than 90 days-net | (29) | 30 | (7) |
| Common stock repurchases for tax withholdings | (1,018) | (651) | (402) |
| Proceeds from issuance of shares | 710 | 745 | 414 |
| Financing-other | (139) | (145) | (239) |
| Cash dividends paid | (6,255) | (6,147) | (6,040) |
| Net cash provided by/(used in) financing activities | (3,829) | (7,079) | (1,769) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 418 | (359) | 9 |
| Net change in cash, cash equivalents and restricted cash | (520) | 1,071 | 5,101 |
| Cash, cash equivalents and restricted cash at January 1 | 14,160 | 13,089 | 7,988 |
| Cash, cash equivalents and restricted cash at December 31 | 13,640 | 14,160 | 13,089 |
| Supplemental data | |||
| Income taxes paid-net of refunds received | 1,948 | 1,723 | 1,564 |
| Interest paid on debt | 2,042 | 1,978 | 1,668 |